|
|
|
|
Dalbavancin: A novel long-acting lipoglycopeptide antibiotic
Dalbavancin is a new lipoglycopeptide antibiotic in phase 3 trials for the treatment of resistant gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). This agent exerts its bactericidal activity by binding to the terminal D-alanyl-D-alanine moiety of peptidoglycan precursors, thus blocking enzymes involved in the final stages of peptidoglycan synthesis and cell wall formation.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Part 1: Comprehensive lipid-lowering update: How to get your high-risk patients to the new NCEP goals
Now that the optimal LDL-cholesterol level for patients with coronary heart disease or its risk equivalents is substantially below 100 mg/dL, consider aggressive lipid-lowering strategies in this group. With the advent of more powerful statins, combination therapy, and newer nonstatin agents, you can help a significantly greater proportion of your patients attain their lipid goals.
|
| |
More>>
|
|
|
|
|
|
The A-R-T of tobacco use counseling with adolescents: A new office approach
This practical strategy to use with young people who smoke includes a new twist that can help you with counseling about any risky behavior.
Every physician is well aware of the importance of preventing or stopping tobacco use among young patients and parents, yet the perceived obstacles to providing such counseling are daunting...
|
| |
More>>
|
|
|
|
|
|
How to recognize and treat IBD
Recognizing, diagnosing, and managing inflammatory bowel disease can all be problematic. Understanding the hallmarks of the disease and keeping up-to-date on the key medical therapies will help you deliver better care. Inflammatory bowel disease (IBD) remains an underdiagnosed condition in the primary care setting.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
Medicare Part D Prescription Coverage
For 40 years, Medicare has dependably covered primary care visits, hospital stays and life-saving surgeries for millions of Americans. That's a great record of supporting older Americans. But even successful programs need modernizing. There's a crucial fact about the new coverage: It's voluntary
|
| |
More>>
|
|
|
|
|
|
Exclusive Survey: The earnings freeze—now it's everybody's problem
In recent years, medicine has displayed a split personality when it comes to income. Primary care physicians by and large have struggled to keep up with the cost of living while specialists have enjoyed nice raises.
That distinction is beginning to disappear, though, as the earnings virus in primary care infects the entire profession. Specialists as well as primary care doctors fell behind inflation last year.
|
| |
More>>
|
|
|
|
|
|
ICD-9: What's changed
New ICD-9-CM diagnosis codes took effect Oct 1. If you haven't already, you need to review the new codes and update your encounter forms and charge tickets because any claims using outdated codes will be rejected. Remember that CMS no longer grants a 90-day grace period for billing discontinued diagnosis codes.
|
| |
More>>
|
|
|
|
|
|
|
|
|
|
